Tabla de contenido
Publicidad
Referencias
1. D. S. Young, Effects of Drugs on Clinical Laboratory Tests, 3rd ed. (Washington, DC: American
Association of Clinical Chemistry, 1990).
2. B. E. Statland, Clinical Decision Levels for Lab Tests, 2nd ed. (Oradell, NJ: Medical Economics Company,
Inc., 1987).
3. NCCLS. Evaluation of Precision Performance of Clinical Chemistry Devices; Approved Guideline. NCCLS
document EP5-A [ISBN 1-56238-368-X]. NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania
19087-1898, USA 1999.
4. NCCLS. Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline. NCCLS
document EP9-A [ISBN 1-56238-283-7]. NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania
19087-1898, USA 1995.
5. P.J. Cornbleet and N. Gochman, "Incorrect Least-Squares Regression Coefficients in Method Comparison
Analysis," Clinical Chemistry 25:3, 432 (1979).
6. NCCLS. Interference Testing in Clinical Chemistry; Proposed Guideline. NCCLS document EP7-P (ISBN 1-
56238-020-6). NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087, 1986.
7. Tietz Textbook of Clinical Chemistry 3rd Edition, CA Burtis and ER Ashwood, ed., WB Saunders Company,
1999, page 1808.
Droxia e Hydrea son marcas comerciales registradas de Bristol-Myers Squibb Company, Princeton (NJ, EE.UU.).
i-STAT es una marca comercial registrada de i-STAT Corporation, East Windsor (NJ, EE.UU.). Vacutainer es una marca comercial registrada
de Becton Dickinson and Company, Franklin Lakes (NJ, EE.UU.). Vitros es una marca comercial registrada de Ortho-Clinical Diagnostics,
Rochester (NY, EE.UU.).
CREATININA
Rev. Date: 04/16/04
Art: 714183-04E
Publicidad
Tabla de contenido
